Literature DB >> 2951292

Bile duct strictures associated with hepatic arterial infusion chemotherapy.

R A Clark, T E Gallant.   

Abstract

We report 6 cases of bile duct strictures in patients receiving intraarterial floxuridine chemotherapy for metastatic colon carcinoma. The computed tomographic and cholangiographic features of these cases mimic those seen with primary sclerosing cholangitis. The postulated mechanism for development of biliary strictures is direct toxicity and/or occlusion of the peribiliary vascular plexus with resultant biliary fibrosis.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2951292     DOI： 10.1007/bf01885126

Source DB:  PubMed          Journal:  Gastrointest Radiol        ISSN： 0364-2356


  28 in total

1.  Complications of long term transbrachial hepatic arterial infusion chemotherapy.

Authors:  M E Clouse; R Ahmed; R B Ryan; R A Oberfield; J A McCaffrey
Journal:  AJR Am J Roentgenol       Date:  1977-11       Impact factor: 3.959

2.  Cholangiographic abnormalities in patients with inflammatory bowel disease.

Authors:  C A Rohrmann; H J Ansel; P C Freeny; F E Silverstein; R L Protell; L F Fenster; T Ball; J A Vennes; S E Silvis
Journal:  Radiology       Date:  1978-06       Impact factor: 11.105

3.  Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.

Authors:  D Hohn; J Melnick; R Stagg; D Altman; M Friedman; R Ignoffo; L Ferrell; B Lewis
Journal:  J Clin Oncol       Date:  1985-01       Impact factor: 44.544

4.  Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver.

Authors:  E Watkins; A M Khazei; K S Nahra
Journal:  Surg Gynecol Obstet       Date:  1970-04

5.  Chemical cholecystitis associated with hepatic artery infusion chemotherapy.

Authors:  C H Carrasco; P C Freeny; V P Chuang; S Wallace
Journal:  AJR Am J Roentgenol       Date:  1983-10       Impact factor: 3.959

Review 6.  Interventional approaches to hepatic tumor treatment.

Authors:  V P Chuang; S Wallace
Journal:  Semin Roentgenol       Date:  1983-04       Impact factor: 0.800

7.  Primary sclerosing cholangitis: findings on cholangiography and pancreatography.

Authors:  R L MacCarty; N F LaRusso; R H Wiesner; J Ludwig
Journal:  Radiology       Date:  1983-10       Impact factor: 11.105

8.  CT appearance of sclerosing cholangitis.

Authors:  N H Rahn; R E Koehler; P J Weyman; C D Truss; S S Sagel; R J Stanley
Journal:  AJR Am J Roentgenol       Date:  1983-09       Impact factor: 3.959

9.  Bile duct cysts secondary to liver infarcts: report of a case and experimental production by small vessel hepatic artery occlusion.

Authors:  J L Doppman; N R Dunnick; M Girton; A S Fauci; M A Popovsky
Journal:  Radiology       Date:  1979-01       Impact factor: 11.105

10.  Bile duct scarring following ethanol embolization of the hepatic artery: an experimental study in monkeys.

Authors:  J L Doppman; M E Girton
Journal:  Radiology       Date:  1984-09       Impact factor: 11.105
View more
  4 in total

Review 1.  Bile duct infarction following intraarterial hepatic chemotherapy mimicking multiple liver metastasis: report of a case and review of the literature.

Authors:  Shailesh Shrikhande; Helmut Friess; Jörg Kleeff; Adrien Tempia; Arthur Zimmermann; Markus Borner; Markus W Büchler
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

2.  Treatment of malignant digestive tract obstruction by combined intraluminal stent installation and intra-arterial drug infusion.

Authors:  A W Mao; Z D Gao; J Y Xu; R J Yang; X S Xiao; T H Jiang; W J Jiang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 3.  Biliary Strictures: Etiologies and Medical Management.

Authors:  Terrance Rodrigues; Justin R Boike
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

4.  Technique for orthotopic reduced-size hepatic transplantation combined with ex vivo liver cut down in the rat.

Authors:  Y Yamaguchi; N Kikuchi; N Miyanari; O Ichiguchi; M Goto; K Mori; M Ogawa
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.